A
Armata Pharmaceuticals Inc
F:TG1N
Armata Pharmaceuticals Inc
F:TG1N
Price:
7.4
EUR
4.96%
Market Closed
Market Cap:
€267.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Armata Pharmaceuticals Inc
F:TG1N
|
US |
|
S
|
SCI JSC
VN:S99
|
VN |
|
Bure Equity AB
STO:BURE
|
SE |
|
Macnica Fuji Electronics Holdings Inc
TSE:3132
|
JP |
|
GLG Corp Ltd
ASX:GLE
|
SG |
|
Manuka Resources Ltd
ASX:MKR
|
AU |
|
Marinus Pharmaceuticals Inc
NASDAQ:MRNS
|
US |
|
Hello Group Inc
NASDAQ:MOMO
|
CN |
|
S&U PLC
LSE:SUS
|
UK |
|
C
|
Creativeforge Games SA
WSE:CFG
|
PL |
|
A
|
Aspen Pharmacare Holdings Ltd
JSE:APN
|
ZA |
Multiples-Based Value
The Multiples-Based Value of one TG1N stock under the Base Case scenario is hidden EUR. Compared to the current market price of 7.4 EUR, Armata Pharmaceuticals Inc is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TG1N Multiples-Based Value
LOCKED
Multiples Across Competitors
TG1N Competitors Multiples
Armata Pharmaceuticals Inc Competitors
Armata Pharmaceuticals Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
A
|
Armata Pharmaceuticals Inc
F:TG1N
|
338.7m EUR | 67 | -7.2 | -13 | -12.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
373.2B USD | 6.1 | 89.2 | 14.8 | 20.5 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
356.4B USD | 6.2 | -96.2 | 951.3 | -107.4 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.4B USD | 5.2 | 24.7 | 14.3 | 14.3 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.9B USD | 5.8 | 20 | 12.5 | 15.4 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.2B USD | 9.6 | 29.2 | 21.9 | 22.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80B USD | 5.6 | 17.8 | 13.2 | 15.1 | |
| AU |
|
CSL Ltd
ASX:CSL
|
69.6B AUD | 3.2 | 35 | 11.5 | 14.5 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
